Medicovestor
Company
Medicovestor develops one asset, in phase 1 (MC001 in pancreatic cancer). Mostly antibody.
- 1
- Asset
- Furthest stage
- Phase 1
- 0
- Trials
- 0
- Signals
Pipeline
1Antibody-drug conjugate targeting pancreatic cancer
Phase 1, Antibody, pancreatic cancer
Full company profiles: pipeline, trials, funding and people.
In the full profile
- Similar companies5